EUVIMEDEUVIMED entdecken
Crossref

Exosomal miR ‐126‐3p: Potential protection against vascular damage by regulating the SLC7A5 / mTOR Signalling pathway in human umbilical vein endothelial cells

Ke Zhu iD, Chen Liu, Xiaofang Guo, Xuting Zhang, Jiaxin Xie, Songmiao Xie, Qing Qi, Bin Yang

Scandinavian Journal of Immunology · 2024

DOI: 10.1111/sji.13354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2024. Verfasst von Ke Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: MicroRNAs, Exosomes, Human Umbilical Vein Endothelial Cells, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disease. Vascular damage is one of the important features of SSc, which affects the progression and prognosis of the disease. MiR‐126‐3p is an important microRNA (miRNA) that regulates vascular structure and function, which can be transported through exosomes. However, the role of miR‐126‐3p in vascular damage in SSc is still unclear. Therefore, we focused on the connection between miR‐126‐3p and vascular damage in SSc, as well as investigated the potential role of miR‐126‐3p in vascular damage in SSc. First, this study successfully extracted extracellular vesicles from clinical plasma samples and characterized the exosomes within them. Then, we predicted and screened the target pathway mammalian/mechanistic target of rapamycin (mTOR) and the target gene SLC7A5 of miR‐126‐3p through online databases. Next, we constructed SSc mice for in vivo studies. The results showed that the expression of miR‐126‐3p was decreased in the plasma exosomes, while the SLC7A5 expression, autophagy, and lipid peroxidation were increased in the aorta. Luciferase reporter gene assays demonstrated that miR‐126‐3p can bind to SLC7A5, resulting in a decrease in its expression. In vitro experiments have shown that exosomal miR‐126‐3p can be internalized by human umbilical vein endothelial cells (HUVECs). The miR‐126‐3p group exhibited enhanced cell viability and tube formation ability, along with increased expression of the vascular formation marker CD31. Additionally, miR‐126‐3p downregulated the protein expression of SLC7A5 and LC3 in HUVECs, while upregulating the protein expression of mTOR, P62, PPARγ, and CPT‐1. However, the effects of miR‐126‐3p on HUVECs were counteracted by mTOR inhibitors and enhanced by mTOR activators. The results indicated that exosomal miR‐126‐3p has the potential to protect against vascular injury in SSc by regulating the SLC7A5/mTOR signalling pathway in HUVECs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsExosomesHuman Umbilical Vein Endothelial CellsTOR Serine-Threonine KinasesSignal TransductionHumansAnimalsMiceScleroderma, SystemicMaleFemaleLarge Neutral Amino Acid-Transporter 1Middle AgedDisease Models, AnimalAdult

Stichwörter der Autor:innen

MiR‐126‐3pexosomesmTORsystemic sclerosisvascular damage

Substanzen

MicroRNAsTOR Serine-Threonine KinasesMIRN126 microRNA, humanMTOR protein, humanLarge Neutral Amino Acid-Transporter 1

Autor:innen und Institutionen

  • Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Dermatology, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Department of Dermatology, Shenzhen People's Hospital, Shenzhen, China.
  • The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Department of Dermatology, The Second Hospital Affiliated to Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Ke Zhu

Zitieren

APA

Zhu, K., Liu, C., Guo, X., Zhang, X., Xie, J., Xie, S., Qi, Q., & Yang, B. (2024). Exosomal miR ‐126‐3p: Potential protection against vascular damage by regulating the SLC7A5 / mTOR Signalling pathway in human umbilical vein endothelial cells. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.13354

Vancouver

Zhu K, Liu C, Guo X, Zhang X, Xie J, Xie S, et al. Exosomal miR ‐126‐3p: Potential protection against vascular damage by regulating the SLC7A5 / mTOR Signalling pathway in human umbilical vein endothelial cells. Scandinavian Journal of Immunology. 2024. doi:10.1111/sji.13354

BibTeX
@article{Zhu2024,
  author = {Zhu, Ke and Liu, Chen and Guo, Xiaofang and Zhang, Xuting and Xie, Jiaxin and Xie, Songmiao and Qi, Qing and Yang, Bin},
  title = {Exosomal miR ‐126‐3p: Potential protection against vascular damage by regulating the SLC7A5 / mTOR Signalling pathway in human umbilical vein endothelial cells},
  journal = {Scandinavian Journal of Immunology},
  year = {2024},
  doi = {10.1111/sji.13354}
}
Kostenlos starten →